Rheumatoid arthritis - continuing authority application form (PB111)

Use this form for the first continuing PBS-subsidised treatment with an originator biological agent for adult patients with severe active rheumatoid arthritis.

You can also use this form to continue PBS-subsidised treatment with infliximab s.c. or upadacitinib for adult patients with severe active rheumatoid arthritis.

‘Biological agent’ refers to:

  • abatacept
  • adalimumab
  • baricitinib
  • certolizumab pegol
  • etanercept
  • golimumab
  • infliximab
  • tocilizumab
  • tofacitinib
  • upadacitinib.

Download and complete the rheumatoid arthritis - continuing authority application form.

To fill in this form digitally you will need a computer and Adobe Acrobat Reader, or a similar program. You can download Adobe Acrobat Reader for free. If you can’t complete the form digitally, you can print it, complete it by hand and return it to us following the instructions on the form.

You can upload this form in HPOS.

If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.

Page last updated: 1 November 2023.
QC 21351